U.S. Bacterial Conjunctivitis Drugs Market to Progress Rapidly, Boosted by Rising Incidence of Bacterial Ophthalmic Infections
Persistence Market Research has published a new research report on the U.S. bacterial conjunctivitis drugs market. As per the report, the cost of treating bacterial conjunctivitis in the United States ranges from US$377 mn to US$857 mn annually. As per the Journal of the American Medical Association (JAMA), the incidence of bacterial conjunctivitis in the United States is 135 in 10,000 people.
View full press release